# FRG1

## Overview
The FRG1 gene, located on chromosome 4q35, encodes the FSHD region gene 1 protein, which is primarily involved in RNA biogenesis and muscle development. This protein is characterized by its fascin-like domain, which suggests a role in actin bundling, a critical process for muscle structure and function. FRG1 is localized in both the nucleus and cytoplasm, where it participates in RNA processing and splicing, as well as in the structural organization of muscle cells. The protein's involvement in these cellular processes is underscored by its interactions with various components of the spliceosome complex and muscle-specific transcription factors. Clinically, alterations in FRG1 expression are associated with facioscapulohumeral muscular dystrophy (FSHD) and certain cancers, highlighting its significance in both muscle physiology and disease (Hansda2017Current; Shubhanjali2024Unveiling; Pistoni2013Rbfox1).

## Structure
The FRG1 protein is encoded by a gene located on chromosome 4q35 and consists of 258 amino acids, resulting in a molecular weight of approximately 30 kDa (Hansda2017Current). The protein's structure includes several key domains and features that are crucial for its function. It contains a nuclear localization signal (NLS) at the N-terminal, a central fascin-like domain, and a bipartite NLS at the carboxy terminal end (Hansda2017Current). The fascin-like domain suggests an involvement in actin bundling, which is important for muscle development (Hansda2017Current).

The secondary structure of FRG1 is primarily composed of 14 beta sheets, organized into pairs of parallel and anti-parallel sheets forming a central motif similar to β-barrel folds. This structure is part of the RICIN superfamily, with similarities to Ricin-type beta-trefoil, a carbohydrate-binding domain (Hansda2017Current). The protein also contains a lipocalin motif characterized by a highly symmetrical all-β protein structure, forming a continuously hydrogen-bonded β-barrel with a ligand-binding site (Hansda2017Current).

FRG1 has two conserved phosphorylation sites, T179 and Y209, which correspond to casein kinase II and tyrosine kinase substrate specificity, indicating potential post-translational modifications (Hansda2017Current). The protein's structural and sequence similarity to proteins like Fascin and FGF18 suggests its involvement in muscle development and angiogenesis (Hansda2017Current).

## Function
The FRG1 gene encodes a protein that plays a significant role in RNA biogenesis and muscle development in healthy human cells. FRG1 is localized in both the nucleus and cytoplasm, with a prominent presence in Cajal bodies and nucleoli, where it co-localizes with nascent mRNA chains, indicating its involvement in RNA processing and splicing (Hansda2017Current; Pistoni2013Rbfox1). The protein is part of the human spliceosome complex and interacts with proteins involved in RNA processing, such as PABPN1 and RNAP-IIO, suggesting a role in RNA biogenesis and splicing (Hansda2017Current).

In the cytoplasm, FRG1 associates with actin filaments, contributing to muscle cell structure and function through actin bundling, which is crucial for muscle contractility and development (Hansda2017Current). The presence of a fascin-like domain in FRG1 supports its role in actin bundling (Hansda2017Current). FRG1 is also implicated in muscle development, influencing the expression of muscle transcription factors like MyoD and Pax3, and is essential for early muscle development in organisms such as Xenopus laevis (Hansda2017Current). These functions highlight FRG1's critical role in maintaining normal muscle physiology and RNA processing in healthy cells.

## Clinical Significance
Alterations in the expression of the FRG1 gene are significantly associated with facioscapulohumeral muscular dystrophy (FSHD), a genetic disorder characterized by muscle weakness and atrophy. In FSHD, the FRG1 gene is often upregulated, which is linked to disruptions in muscle development and function. This upregulation is not consistently observed across all FSHD cases, indicating variability in its expression among patients (Bodega2009Remodeling). The overexpression of FRG1 has been shown to lead to splicing perturbations in muscle tissues, particularly affecting the splicing of Calpain 3, a gene associated with limb girdle muscular dystrophy. This splicing alteration is linked to the downregulation of the splicing factor Rbfox1, contributing to muscle differentiation defects (Pistoni2013Rbfox1).

In addition to its role in muscular dystrophy, FRG1 has been implicated in cancer. Low expression levels of FRG1 in breast cancer patients are associated with a higher frequency of TP53 mutations, which are crucial in cancer development. FRG1's expression influences cancer-related processes such as angiogenesis, cell proliferation, and migration, suggesting its role as a tumor suppressor in various cancers, including breast and prostate cancer (Shubhanjali2024Unveiling).

## Interactions
The FRG1 protein is involved in several physical interactions with other proteins and nucleic acids, playing a crucial role in muscle development and RNA processing. It contains a fascin-like domain, indicative of actin-binding proteins, and participates in actin bundling by forming homodimers and heterodimers. In C. elegans, FRG1 is present in both the nucleus and cytoplasm, forming aggregations similar to dense bodies, which are homologous to vertebrate focal adhesions. These dense bodies are involved in anchoring the actin cytoskeleton to the basal lamina and hypodermis, suggesting a role in muscle regulation and motility (Hansda2017Current).

FRG1 is also involved in RNA processing, as it co-localizes in sub-nuclear structures involved in mRNA and rRNA biogenesis. It has been identified in the C-complex of the human spliceosome and interacts with several proteins, including PABPN1, which is involved in polyadenylation of long non-coding RNAs, and hyper-phosphorylated RNAP-IIO, associated with the elongation complex and assembly of early spliceosome complex. FAM71B, a conserved Cajal body and nuclear speckles protein, has also been identified as a FRG1 interacting protein through yeast-two hybridization screening and GST pull down assays (Hansda2017Current).

FRG1 interacts with proteins associated with the spliceosome complex, regulating the splicing of early muscle development-related genes. It also interacts with MyoD and Pax3, affecting muscle development gene expression. The structural similarity of FRG1 with proteins like Fascins and FGF18 suggests that FRG1 may act as a muscle-specific growth factor or angiogenic regulator (Hansda2017Current).


## References


[1. (Bodega2009Remodeling) Beatrice Bodega, Gabriella Di Capua Ramirez, Florian Grasser, Stefania Cheli, Silvia Brunelli, Marina Mora, Raffaella Meneveri, Anna Marozzi, Stefan Mueller, Elena Battaglioli, and Enrico Ginelli. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (fshd) locus and upregulation of fshd-related gene 1 (frg1) expression during human myogenic differentiation. BMC Biology, July 2009. URL: http://dx.doi.org/10.1186/1741-7007-7-41, doi:10.1186/1741-7007-7-41. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/1741-7007-7-41)

[2. (Hansda2017Current) Arman Kunwar Hansda, Ankit Tiwari, and Manjusha Dixit. Current status and future prospect of fshd region gene 1. Journal of Biosciences, 42(2):345–353, April 2017. URL: http://dx.doi.org/10.1007/s12038-017-9681-x, doi:10.1007/s12038-017-9681-x. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12038-017-9681-x)

[3. (Shubhanjali2024Unveiling) Shubhanjali Shubhanjali, Talina Mohapatra, Rehan Khan, and Manjusha Dixit. Unveiling frg1’s dna repair role in breast cancer. Scientific Reports, August 2024. URL: http://dx.doi.org/10.1038/s41598-024-70368-9, doi:10.1038/s41598-024-70368-9. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-70368-9)

[4. (Pistoni2013Rbfox1) Mariaelena Pistoni, Lily Shiue, Melissa S. Cline, Sergia Bortolanza, Maria Victoria Neguembor, Alexandros Xynos, Manuel Ares, and Davide Gabellini. Rbfox1 downregulation and altered calpain 3 splicing by frg1 in a mouse model of facioscapulohumeral muscular dystrophy (fshd). PLoS Genetics, 9(1):e1003186, January 2013. URL: http://dx.doi.org/10.1371/journal.pgen.1003186, doi:10.1371/journal.pgen.1003186. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1003186)